Annovis Bio prices $21M public offering; shares slump

Seeking Alpha · November 5, 2026, 14:00 UTC

Tickers: $ANVS

Topics: capital raising dilution stock offering

Read the full article at Seeking Alpha

Part of the story Annovis Bio Shares Drop Over 27% Following Announcement of Public Offering (3 articles)

More World news

Team, Inc. (TISI) Reports Q3 2026 Results Amid Turnaround Deferrals and Geopolitical Disruptions Motley Fool · November 12, 2026, 19:44 UTC
Berkshire Hathaway Stock Reaches Record Levels Amid CEO Greg Abel's Leadership Motley Fool · November 12, 2026, 19:45 UTC
Data I/O Reports Q3 2026 Results Amid V-TEK Acquisition and Automotive Softness Motley Fool · November 12, 2026, 19:45 UTC
Google Unveils Gemini 4 Hydrogen AI Model Optimized for Coding Efficiency Seeking Alpha · November 12, 2026, 19:44 UTC
CMS Announces Final Valuations and Reimbursement Rates for New ESD CPT Codes PR Newswire · November 12, 2026, 19:43 UTC
IRS Announces 2027 Retirement Contribution Limits and Social Security COLA Increase Motley Fool · November 12, 2026, 19:37 UTC
Yesway Reaffirms 2026 EBITDA Guidance and Outlines Texas Allsup’s Conversion Timeline Seeking Alpha · November 12, 2026, 19:40 UTC
Boost Run Reports 496% Year-Over-Year Revenue Growth in Q3 2026 Seeking Alpha · November 12, 2026, 19:40 UTC
AiPrise Launches Token Sharing Infrastructure to Streamline Compliance Verification PR Newswire · November 12, 2026, 19:39 UTC
Barclays Upgrades Steel Producers Cleveland-Cliffs and Reliance Amid Market Selloff Seeking Alpha · November 12, 2026, 19:32 UTC